Case Control Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Mar 15, 2024; 16(3): 687-698
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.687
Table 1 Correlation between periodic acid Schiff expression and clinicopathologic features (n = 83), n (%)
Factors
Total
PAS
P value
n = 83
≤ 50% positive
> 50% positive
Age (yr)0.583
≤ 6063 (75.9)24 (72.7)39 (78.0)
> 6020 (24.1)9 (27.3)11 (22.0)
Gender0.898
Male32 (38.6)13 (39.4)19 (38.0)
Female51 (61.4)20 (60.6)31 (62.0)
Tumor diameter0.347
≤ 343 (51.8)15 (45.5)28 (56.0)
> 340 (48.2)18 (54.5)22 (44.0)
Vessel carcinoma embolus0.608
No33 (39.8)12 (36.4)21 (42.0)
Yes50 (60.2)21 (63.6)29 (58.0)
Lymph node metastasis0.331
Negative33 (39.8)11 (33.3)22 (44.0)
Positive50 (60.2)22 (66.7)28 (56.0)
Tumor stage0.006
Early21 (25.3)3 (9.1)18 (36.0)
Advanced62 (74.7)30 (90.9)32 (64.0)
Ki670.394
≤ 50%62 (74.7)23 (69.7)39 (78.0)
> 50%21 (25.3)10 (30.3)11 (22.0)
P530.281
Negative31 (37.3)10 (30.3)21 (42.0)
Positive52 (62.7)23 (69.7)29 (58.0)
HER20.283
Negative63 (75.9)23 (69.7)40 (80.0)
Positive20 (24.1)10 (30.3)10 (20.0)
Table 2 Univariate and multivariate Cox regression analysis based on clinicopathologic parameters for 83 signet ring cell carcinoma patients
Univariate analysis
Multivariate analysis
HR
95%CI
P value
HR
95%CI
P value
Age (yr)
≤ 601
> 601.4610.624-3.4180.382
Gender
Male1
Female0.8650.384-1.9490.727
Tumor diameter
≤ 311
> 34.4281.750-11.1990.0022.7611.086-7.0200.033
Venous tumor emboli
No1
Yes3.6341.351-9.7750.011
Lymph node metastasis
No1
Yes3.0061.120-8.0660.029
Tumor stage
Early11
Advanced42.2321.201-1485.1600.0391598580.000-2.26E+1530.945
Ki67
≤ 50%1
> 50%2.2540.984-5.1650.055
P53
Negative1
Positive2.5320.995-6.4430.051
HER2
Negative1
Positive1.2320.487-3.1140.659
PAS
> 50%11
≤ 50%5.2842.164-12.90503.8090.108-0.6400.003
AB
≤ 50%1
> 50%0.9850.970-3.1141.002
A/P
≤ 50%1
> 0.51.4021.028-1.9100.033